HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic importance of mitral regurgitation complicated by acute myocardial infarction during a 5-year follow-up period in the drug-eluting stent era.

AbstractBACKGROUND:
Mitral regurgitation (MR) is a frequent complication of left-ventricular dysfunction, with an incidence ranging from 13 to 59% after acute myocardial infarction (AMI), which is associated with poor clinical outcome. The aim of this study was to assess the clinical and angiographic characteristics associated with MR, the incidence and predictors of MR, and the outcomes of MR after AMI in those who were successfully treated with primary percutaneous coronary intervention (PCI) using a drug-eluting stent.
METHODS:
We analyzed a multicenter all-comer AMI registry and identified 4748 patients between January 2004 and December 2009. Of these, 1894 patients were treated with PCI using a drug-eluting stent and had MR. The association between MR and the composite of major adverse cardiac and cerebrovascular events (MACCE; all-cause death, recurrent nonfatal myocardial infarction, stroke, and any revascularization) was examined.
RESULTS:
Patients with MR after the index PCI showed significantly higher cumulative incidence of MACCE compared with no-MR patients over the 5-year survival period (P=0.002). When the MR groups were compared on the basis of the severity of MR, ranging from mild to severe grades, a higher grade of MR was found to be associated with a higher incidence of MACCE (P<0.001). Multivariate Cox proportional hazard analysis revealed that no reflow, left-ventricular ejection fraction less than 50%, and anemia, in addition to MR, were consistently associated with increased all-cause death during the 5-year period (adjusted hazard ratio 1.408, 95% confidence interval 1.052-1.884, P=0.021).
CONCLUSION:
MR after AMI in patients successfully treated with primary PCI was associated with poor long-term outcome regardless of ST-segment elevation at diagnosis during the drug-eluting stent era.
AuthorsTae-Hoon Kim, Kwan Yong Lee, Young Choi, Ha-Wook Park, Young Soo Lee, Yoon Seok Koh, Hun-Jun Park, Pum-Joon Kim, Kiyuk Chang, Wook Sung Chung, Dong-Bin Kim, Sung-Ho Her, Chul Soo Park, Jong Min Lee, Hee-Yeol Kim, Ki Dong Yoo, Doo Soo Jeon, Youngkeun Ahn, Myung-Ho Jeong, Ki-Bae Seung
JournalCoronary artery disease (Coron Artery Dis) Vol. 27 Issue 2 Pg. 109-15 (Mar 2016) ISSN: 1473-5830 [Electronic] England
PMID26626143 (Publication Type: Journal Article)
Topics
  • Age Factors
  • Aged
  • Atrial Fibrillation (epidemiology)
  • Drug-Eluting Stents
  • Female
  • Humans
  • Hypercholesterolemia (epidemiology)
  • Incidence
  • Male
  • Middle Aged
  • Mitral Valve Insufficiency (etiology)
  • Mortality
  • Myocardial Infarction (complications, epidemiology, surgery)
  • Myocardial Revascularization (statistics & numerical data)
  • No-Reflow Phenomenon (epidemiology)
  • Percutaneous Coronary Intervention
  • Prognosis
  • Proportional Hazards Models
  • Recurrence
  • Registries
  • Retrospective Studies
  • Risk Factors
  • Stroke (epidemiology)
  • Stroke Volume
  • Ventricular Dysfunction, Left (etiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: